Related Experiment Video
Updated: May 5, 2026

11:25
Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
Published on: March 8, 2024
1.1K
Retransplantations in the Hungarian liver transplant program
1Departure of Transplantation and Surgery, Semmelweis University, Budapest, Hungary.
Transplantation Proceedings
|December 10, 2013
Summary
Liver retransplantation (ReOLT) outcomes were analyzed, revealing stable early ReOLT rates but an increase in late ReOLT due to biliary complications. Hepatitis C virus recurrence was not a primary driver for late ReOLT.
Area of Science:
- Hepatology
- Transplantation Medicine
- Surgical Outcomes
Background:
- Liver retransplantation (ReOLT) is a significant consideration following primary liver transplantation (OLT).
- Understanding trends and indications for ReOLT is crucial for improving patient and graft survival.
- Previous studies have highlighted various reasons for OLT failure necessitating retransplantation.
Purpose of the Study:
- To analyze the trends, indications, and outcomes of liver retransplantation (ReOLT) over a 17-year period.
- To compare the survival rates of ReOLT with primary OLT.
- To identify factors influencing the need for and success of ReOLT.
Main Methods:
- Retrospective analysis of 512 liver transplantation (OLT) patient records from 1995 to 2012.
- Detailed review of 34 cases undergoing liver retransplantation (ReOLT), categorizing by timing (early vs. late) and indication.
- Comparison of cumulative patient and graft survival rates between primary OLT and ReOLT.
Main Results:
- The rate of early ReOLT (within 3 months) remained consistent, primarily indicated by hepatic artery thrombosis.
- A significant increase in late ReOLT (beyond 3 months) was observed, predominantly due to nonanastomotic biliary stenosis.
- Cumulative survival rates for ReOLT (61%, 52%, 52%) were significantly lower than for primary OLT (81%, 75%, 70%) (P = .03).
- Hepatitis C virus recurrence was not a major indication for late ReOLT due to center policy.
Conclusions:
- While early ReOLT characteristics remained stable, late ReOLT rates increased, largely driven by biliary complications.
- The lower survival rates in ReOLT underscore the challenges associated with repeat liver transplantation.
- Hepatitis C virus recurrence is managed proactively, preventing its emergence as a common indication for late ReOLT.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827
Kidney Transplant II: Surgical Procedure
926
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
926
Tissue Transplantation
1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K

